3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Sarcoma, Ewing
2
Sarcoma
2
Osteosarcoma
2
Vascular Neoplasms
1
Solitary Fibrous Tumors
1
Smooth Muscle Tumor
1
Sarcoma, Clear Cell
1
Rhabdomyosarcoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neurofibrosarcoma
1
Nerve Sheath Neoplasms
1
Neoplasms, Adipose Tissue
1
Myoepithelioma
1
Malignant mesenchymal tumor
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Liposarcoma, Myxoid
1
Liposarcoma
1
Hodgkin Disease
1
Histiocytoma, Angiomatoid Fibrous
1
Hemangiosarcoma
1
Hemangioendothelioma, Epithelioid
1
Granuloma, Plasma Cell
1
Granular Cell Tumor
1
Glomus Tumor
1
Fibrosarcoma
1
Disorders of Sex Development
1
Dermatofibrosarcoma
1
Chondrosarcoma, Extraskeletal Myxoid
1
Interventions
Nivolumab
21
pembrolizumab
18
Ipilimumab
14
Specimen Handling
13
Magnetic Resonance Spectroscopy
8
CTLA-4 Antigen
7
trametinib
5
binimetinib
5
Opdualag
5
relatlimab
4
dabrafenib
4
atezolizumab
3
Standard of Care
3
Paclitaxel
3
Introns
3
Interferon alpha-2
3
Gemcitabine
3
Blood Specimen Collection
3
Biopsy
3
ulixertinib
2
sargramostim
2
lenvatinib
2
fludarabine phosphate
2
fludarabine
2
encorafenib
2
capivasertib
2
cabozantinib
2
aldesleukin
2
X-Rays
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Ifosfamide
×
30 days
×
Clear all
No trials found.